Latest News | Dr Reddy's Laboratories Launches Generic Version of Fesoterodine Fumarate Tablets in US
Get latest articles and stories on Latest News at LatestLY. Dr Reddy's Laboratories Ltd on Friday said it has launched its generic version of fesoterodine fumarate extended-release tablets used for treating overactive bladder in the US market.
New Delhi, Jul 8 (PTI) Dr Reddy's Laboratories Ltd on Friday said it has launched its generic version of fesoterodine fumarate extended-release tablets used for treating overactive bladder in the US market.
The launch follows the approval granted by the US Food and Drug Administration (USFDA), the pharma company said in a regulatory filing.
Also Read | Intelligence Bureau Recruitment 2022: Applications Invited for 766 Posts at mha.gov.in; Check Details Here.
The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added.
Citing IQVIA data, Dr Reddy's said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022.
Also Read | Vivo Y77 5G MediaTek Dimensity 930 SoC Debuts in China.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)